425 related articles for article (PubMed ID: 6119340)
1. Drug therapy for peptic ulcer: drugs that act on the gastric mucosa.
Kauffman GL
J Clin Gastroenterol; 1981; 3(Suppl 2):95-101. PubMed ID: 6119340
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of peptic ulcer disease.
Andersen BN
Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
[TBL] [Abstract][Full Text] [Related]
4. Drug therapy of peptic ulcer disease.
Peppercorn MA
Compr Ther; 1983 Nov; 9(11):47-52. PubMed ID: 6139199
[TBL] [Abstract][Full Text] [Related]
5. Ulcer-healing drugs and endogenous prostaglandins.
Guslandi M
Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):398-402. PubMed ID: 2864318
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
Thomson AB; Mahachai V
Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
[TBL] [Abstract][Full Text] [Related]
7. Problems associated with medical treatment of peptic ulcer disease.
Zimmerman TW
Am J Med; 1984 Nov; 77(5B):51-6. PubMed ID: 6095662
[TBL] [Abstract][Full Text] [Related]
8. [Peptic ulcer: new aspects of conservative therapy].
Bernoulli R
Schweiz Med Wochenschr; 1977 May; 107(18):618-22. PubMed ID: 17157
[TBL] [Abstract][Full Text] [Related]
9. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
Tytgat GN; Nio CY
Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and clinical aspects of some drugs used in peptic ulcer treatment.
Abrahamsson H; Dotevall G
Scand J Gastroenterol Suppl; 1979; 55():117-20. PubMed ID: 395633
[TBL] [Abstract][Full Text] [Related]
11. Current concepts in clinical therapeutics: peptic ulcer disease.
Siepler JK; Mahakian K; Trudeau WT
Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic options for the control of peptic ulcer disease.
Levine JB
Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
[No Abstract] [Full Text] [Related]
13. [Morphology of the gastric mucosa in patients with duodenal ulcer treated with bismuth-containing drugs].
Mach T
Folia Med Cracov; 1995; 36(1-4):53-75. PubMed ID: 8834668
[TBL] [Abstract][Full Text] [Related]
14. Treatment of duodenal ulcer.
Eliakim R; Rachmilewitz D
Rev Clin Basic Pharm; 1985; 5(3-4):215-33. PubMed ID: 2881325
[TBL] [Abstract][Full Text] [Related]
15. Review: effect of anti-ulcer drugs on gastric mucous barrier and possible cyclic AMP involvement.
Guslandi M
Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):140-3. PubMed ID: 6247291
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacologic treatment of ulcers].
Honorato Pérez J; Azanza Perea JR; Cuena Boy R
Rev Med Univ Navarra; 1984 Jun; 28(2):53-8. PubMed ID: 6149611
[No Abstract] [Full Text] [Related]
17. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Wagstaff AJ; Benfield P; Monk JP
Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandins in pathophysiology of peptic ulcer disease.
Konturek SJ
Dig Dis Sci; 1985 Nov; 30(11 Suppl):105S-108S. PubMed ID: 3863751
[TBL] [Abstract][Full Text] [Related]
19. Effects of antisecretory drugs on mucosal erosions induced by intragastric distension in rats: a comparative study.
Martí-Cabrera M; Esplugues JV; Martí-Bonmati L; Sarria B; Vento A; Martí-Bonmati E; Gil L; Esplugues J
Methods Find Exp Clin Pharmacol; 1988 Jan; 10(1):13-6. PubMed ID: 3162756
[TBL] [Abstract][Full Text] [Related]
20. [Current aspects of the therapy of gastroduodenal peptic ulcer].
Castro Lde P
Rev Hosp Clin Fac Med Sao Paulo; 1983; 38(2):90-102. PubMed ID: 6139870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
